Jaypee Infratech Q2 loss widens to Rs 613.87 crore
News2021-11-02
22 Views
The company#39;s total expenses increased to Rs 865.98 crore during July-September quarter of this fiscal year from Rs 693.32 crore in the year-ago period.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
NRx Pharmaceuticals (Nasdaq: NRXP): FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir
